ALZUMAb

Biocon offers a wide range of immunotherapy which includes alzumab?. Composition: each vial contains 25 mg of itolizumab. Itolizumab is a humanized recombinant anti-cd-6 monoclonal antibody. Each ml contains 5 mg of itolizumab for intravenous use. Mechanism of action: itolizumab is a humanized recombinant anti-cd6 mab of immunoglobulin (ig) g1 isotype that binds to domain 1 of cd6. The cd6 leukocyte differentiation antigen is a membrane glycoprotein mainly expressed on the surface of mature thymocytes, in most peripheral blood cd3+ t-cells and in a subtype of b-lymphocytes called b1a cells. Indications: it is indicated for the treatment of patients with active moderate to severe chronic plaque psoriasis who are candidates for systemic therapy